Standardization and bioavailability of ayurvedic drug lauha bhasma- part -ii comparative bioavailability studies
- PMID: 22556733
- PMCID: PMC3331201
Standardization and bioavailability of ayurvedic drug lauha bhasma- part -ii comparative bioavailability studies
Abstract
After analyzing the Lauha Bhasma samples qualitatively and quantitatively, in-vivo studies on healthy adult male rabbits were carried out. Randomly selected anaemic rabbits were divided into different groups and three variants of Lauha Bhasma and ferrous sulphate sample were administered to each group. The effect of each formulation was monitored by measuring the haemoglobin (Hb) content spectrophotometrically (cyanomethaemoglobin method). Increase in the haemoglobin content was found to be significant in case of the ayurvedic formulations as compared to the ferrous sulphate sample.
Similar articles
-
Standardization and bioavailabililty of ayurvedic drug lauha bhasma part-1 physical and chemical evaluation.Anc Sci Life. 1995 Oct;15(2):129-36. Anc Sci Life. 1995. PMID: 22556731 Free PMC article.
-
Standard manufacturing procedure of Teekshna lauha bhasma.J Ayurveda Integr Med. 2016 Apr-Jun;7(2):100-8. doi: 10.1016/j.jaim.2015.08.003. Epub 2016 Jul 20. J Ayurveda Integr Med. 2016. PMID: 27450759 Free PMC article.
-
Further studies on chemical evaluation of lauha bhasma iii.Anc Sci Life. 1996 Jul;16(1):26-33. Anc Sci Life. 1996. PMID: 22556767 Free PMC article.
-
Anti-diabetic formulations of Nāga bhasma (lead calx): A brief review.Anc Sci Life. 2013 Jul;33(1):52-9. doi: 10.4103/0257-7941.134609. Anc Sci Life. 2013. PMID: 25161332 Free PMC article. Review.
-
Bhasma : The ancient Indian nanomedicine.J Adv Pharm Technol Res. 2014 Jan;5(1):4-12. doi: 10.4103/2231-4040.126980. J Adv Pharm Technol Res. 2014. PMID: 24696811 Free PMC article. Review.
Cited by
-
Synthesis and characterization of Vanga bhasma.J Ayurveda Integr Med. 2019 Apr-Jun;10(2):111-118. doi: 10.1016/j.jaim.2017.05.003. Epub 2018 Jan 5. J Ayurveda Integr Med. 2019. PMID: 29310904 Free PMC article.
-
Nanoscale Diamond-Based Formulation as an Immunomodulator and Potential Therapeutic for Lymphoma.Front Pharmacol. 2022 Apr 4;13:852065. doi: 10.3389/fphar.2022.852065. eCollection 2022. Front Pharmacol. 2022. PMID: 35444547 Free PMC article.
LinkOut - more resources
Full Text Sources